Bayer Must Face FCA Claims Over Off-Label Trasylol Marketing
By Margaret Harding McGill · June 9, 2015, 6:41 PM EDT
A New Jersey federal judge declined Monday to reconsider his order allowing two False Claims Act claims in a whistleblower's long-running suit against Bayer Corp. for allegedly pushing off-label uses of...
To view the full article, register now.